TEVA

Answering the Question: When to Sell a Stock-Part 1A

2019-08-05

Research Articles

Introduction I’m going to start this article with the same opening statement that I utilized in two previous articles I wrote on knowing when to sell a stock. The most common complaint that I have heard from investors over my 49+ years in the financial services industry is as follows: “Everyone wants to tell me […]

A Comprehensive Look At Dividend Growth Stock Valuations Sector By Sector: Part 2

2016-08-26

Research Articles

Introduction Finding attractively valued dividend growth stocks is getting harder and harder to do.  The overall market has been on a relentless advance for many years now, and high quality dividend paying growth stocks have been leaders.  Consequently, valuations have become extended beyond historical norms and I contend prudence.  Nevertheless, there are attractive dividend growth […]

Invest In Stocks With A Margin of Safety To Reduce Risk And Enhance Returns

2013-09-13

Research Articles

Introduction Of all of the many sound investing principles that legendary teacher and investor Ben Graham put forward, he believed that his concept of “margin of safety” was the most important of all.  This investment lesson was so deeply ingrained into the mind of Ben Graham’s most famous student, Warren Buffett, that he created his […]

A True Investor’s Most Important Performance Measurement

2012-04-16

Research Articles

Although most people either fail to realize it, or simply refused to accept it, every stock portfolio has two separate and distinct performances.  The first, and in my opinion, the least important, is stock price movement.  If you buy a stock at $10 a share and it goes to $15 a share it’s a good […]

Teva Pharmaceutical: Dividends, Earnings And Valuation Analysis

2012-03-02

Research Articles

. . . . Teva Pharmaceutical (TEVA): A Dividend Contender with 13 Consecutive Years of Dividend Increases Since dividends are paid out of earnings, a clear perspective of a company’s historical earnings growth record is a vital component of a dividend investor’s prudent due diligence process. The following graph plots Teva Pharmaceutical’s earnings per share […]

42 Dividend Contenders for Above-Average Total Return

2012-01-11

Research Articles

With interest rates hovering near all-time lows, investors needing income are faced with very limited choices.  The traditional high yield available from bonds and other fixed income vehicles are no longer available to meet the needs of retirees needing income to live off.  Moreover, it is almost a certainty that today’s low yields are not […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.